APA (7th ed.) Citation

R, F., B, T., J, K., C, S., M, T., M, B., . . . FS, T. (2025). Hemoadsorption therapy in severe rhabdomyolysis: A report from the international, prospective COSMOS (CytOSorb® TreatMent of Critically ill PatientS) registry. Renal failure, 47(1), 2600720. https://doi.org/10.1080/0886022X.2025.2600720

Chicago Style (17th ed.) Citation

R, Ferrer, et al. "Hemoadsorption Therapy in Severe Rhabdomyolysis: A Report from the International, Prospective COSMOS (CytOSorb® TreatMent of Critically Ill PatientS) Registry." Renal Failure 47, no. 1 (2025): 2600720. https://doi.org/10.1080/0886022X.2025.2600720.

MLA (9th ed.) Citation

R, Ferrer, et al. "Hemoadsorption Therapy in Severe Rhabdomyolysis: A Report from the International, Prospective COSMOS (CytOSorb® TreatMent of Critically Ill PatientS) Registry." Renal Failure, vol. 47, no. 1, 2025, p. 2600720, https://doi.org/10.1080/0886022X.2025.2600720.